Wolverine Asset Management’s European Biotech Acquisition Corp. Units EBACU Stock Holding History

Wolverine Asset Management’s Portfolio EBACU Stock Details EBACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,759	Closed	-$47K	–	2550
2022 Q3	$47K	Sell	4,759 -3,611	-43%	-$35.7K	﹤0.01%	1618
2022 Q2	$81K	Buy	8,370 +3,023	+57%	+$29.8K	﹤0.01%	1435
2022 Q1	$52K	Buy	5,347 +4,346	+434%	+$43K	﹤0.01%	1495
2021 Q4	$9K	Buy	+1,001	New	+$9.92K	﹤0.01%	1868
2021 Q3	–	Sell	-3,933	Closed	-$39K	–	2530
2021 Q2	$39K	Buy	+3,933	New	+$39.4K	﹤0.01%	1747

Other funds holding EBACU

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

LCM

Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

TAM

Terrapin Asset Management Miami, Florida $87.8M AUM 16.84% 1-Year Est. Return

Wolverine Asset Management's EBACU Position: Q4 2022 in Review

Wolverine Asset Management sold out of European Biotech Acquisition Corp. Units (EBACU) in Q4 2022, closing a stake of 4,759 shares — an estimated $47K sold.

Wolverine Asset Management first reported a position in EBACU in Q2 2021 and held it in 5 quarters. The position peaked at $81K in Q2 2022. 11 funds tracked by Wall St. Rank hold EBACU as of Q4 2022.

Wolverine Asset Management reported no remaining European Biotech Acquisition Corp. Units position as of Q4 2022 after selling out during the quarter.
Wolverine Asset Management sold 4,759 European Biotech Acquisition Corp. Units shares in Q4 2022, an estimated $47K.
Wolverine Asset Management first reported a position in European Biotech Acquisition Corp. Units in Q2 2021 and held it in 5 quarters.
Wolverine Asset Management's European Biotech Acquisition Corp. Units position peaked at $81K in Q2 2022.
11 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Units as of Q4 2022.

Based on Wolverine Asset Management's 13F filing for Q4 2022, filed 1 Feb 2023.